BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Córdoba KM, Jericó D, Sampedro A, Jiang L, Iraburu MJ, Martini PG, Berraondo P, Avila MA, Fontanellas A. Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases. mRNA-Based Therapeutics 2022. [DOI: 10.1016/bs.ircmb.2022.03.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Jericó D, Córdoba KM, Sampedro A, Jiang L, Joucla G, Cabanne C, Lanciego JL, Martini PGV, Berraondo P, Ávila MA, Fontanellas A. Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment. Life (Basel) 2022;12. [PMID: 36430993 DOI: 10.3390/life12111858] [Reference Citation Analysis]
2 Gurung S, Timmermand OV, Perocheau D, Gil-martinez AL, Minnion M, Touramanidou L, Fang S, Messina M, Khalil Y, Barber AR, Edwards RS, Finn PF, Cavedon A, Siddiqui S, Rice L, Martini PG, Mills PB, Waddington SN, Gissen P, Eaton S, Ryten M, Feelisch M, Frassetto A, Witney TH, Baruteau J. mRNA therapy restores ureagenesis and corrects glutathione metabolism in argininosuccinic aciduria.. [DOI: 10.1101/2022.10.19.512931] [Reference Citation Analysis]